NO983776L - 1,4-Dihydropyridin-forbindelser som Bradykinin-antagonister - Google Patents

1,4-Dihydropyridin-forbindelser som Bradykinin-antagonister

Info

Publication number: NO983776L
Authority: NO; Norway
Prior art keywords: bradykinin; octyl; alkyl; dihydropyridine compounds; bradykinin antagonists
Prior art date: 1996-02-19

Application number

NO983776A

Other languages

English (en)

Norwegian (no)

Other versions

NO983776D0 (no

Inventor

Takafumi Ikeda

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-19

Filing date

1998-08-18

Publication date

1998-08-18

1998-08-18 Application filed by Pfizer filed Critical Pfizer

1998-08-18 Publication of NO983776D0 publication Critical patent/NO983776D0/no

1998-08-18 Publication of NO983776L publication Critical patent/NO983776L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)
Pyridine Compounds (AREA)

NO983776A 1996-02-19 1998-08-18 1,4-Dihydropyridin-forbindelser som Bradykinin-antagonister NO983776L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IB9600132		1996-02-19
PCT/IB1997/000058 WO1997030048A1 (en)	1996-02-19	1997-01-27	1,4-dihydropyridine compounds as bradykinin antagonists

Publications (2)

Publication Number	Publication Date
NO983776D0 NO983776D0 (no)	1998-08-18
NO983776L true NO983776L (no)	1998-08-18

Family

ID=11004406

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO983776A NO983776L (no)	1996-02-19	1998-08-18	1,4-Dihydropyridin-forbindelser som Bradykinin-antagonister

Country Status (34)

Country	Link
US (1)	US6131226A (de)
EP (1)	EP0882044B1 (de)
JP (1)	JP3167335B2 (de)
KR (1)	KR19990082678A (de)
CN (1)	CN1211251A (de)
AR (1)	AR005841A1 (de)
AT (1)	ATE220676T1 (de)
AU (1)	AU1396497A (de)
BG (1)	BG102678A (de)
BR (1)	BR9707568A (de)
CA (1)	CA2245857C (de)
CO (1)	CO4650041A1 (de)
CZ (1)	CZ258698A3 (de)
DE (1)	DE69714019T2 (de)
DK (1)	DK0882044T3 (de)
ES (1)	ES2177921T3 (de)
HN (1)	HN1997000013A (de)
HR (1)	HRP970094A2 (de)
HU (1)	HUP9902810A3 (de)
ID (1)	ID16434A (de)
IL (1)	IL124867A0 (de)
IS (1)	IS4783A (de)
MA (1)	MA26419A1 (de)
NO (1)	NO983776L (de)
NZ (1)	NZ325455A (de)
OA (1)	OA10712A (de)
PE (1)	PE36298A1 (de)
PL (1)	PL328514A1 (de)
PT (1)	PT882044E (de)
SI (1)	SI0882044T1 (de)
TN (1)	TNSN97037A1 (de)
TR (1)	TR199801593T2 (de)
WO (1)	WO1997030048A1 (de)
ZA (1)	ZA971357B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH11106375A (ja) *	1997-08-18	1999-04-20	Pfizer Pharmaceut Inc	ブラジキニンアンタゴニストとしての光学的に活性な１，４−ジヒドロピリジン化合物
EP1110962A1 (de) *	1999-12-10	2001-06-27	Pfizer Inc.	Verfahren zur herstellung von 1,4-dihydropyridine verbindungen
US6653313B2 (en) *	2000-08-10	2003-11-25	Warner-Lambert Company Llc	1,4-dihydropyridine compounds as bradykinin antagonists
GB0427281D0 (en) *	2004-12-14	2005-01-12	3M Innovative Properties Co	Methods of providing medicinal metal components having through holes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5120750A (en) *	1989-01-17	1992-06-09	Synphar Laboratories, Inc.	Generation of 1,4-dihydropyridine derivatives
WO1996006083A1 (en) *	1994-08-24	1996-02-29	Pfizer Pharmaceuticals Inc.	2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists
MX9701245A (es) *	1996-02-19	1998-04-30	Pfizer	Compuestos de 1,4 dihidropiridina.

1996
- 1996-02-18 TN TNTNSN97037A patent/TNSN97037A1/fr unknown
1997
- 1997-01-27 DE DE69714019T patent/DE69714019T2/de not_active Expired - Fee Related
- 1997-01-27 CN CN97192240A patent/CN1211251A/zh active Pending
- 1997-01-27 US US09/125,137 patent/US6131226A/en not_active Expired - Fee Related
- 1997-01-27 NZ NZ325455A patent/NZ325455A/xx unknown
- 1997-01-27 WO PCT/IB1997/000058 patent/WO1997030048A1/en not_active Ceased
- 1997-01-27 IL IL12486797A patent/IL124867A0/xx unknown
- 1997-01-27 CA CA002245857A patent/CA2245857C/en not_active Expired - Fee Related
- 1997-01-27 ES ES97900401T patent/ES2177921T3/es not_active Expired - Lifetime
- 1997-01-27 KR KR1019980706424A patent/KR19990082678A/ko not_active Ceased
- 1997-01-27 AU AU13964/97A patent/AU1396497A/en not_active Abandoned
- 1997-01-27 PT PT97900401T patent/PT882044E/pt unknown
- 1997-01-27 SI SI9730361T patent/SI0882044T1/xx unknown
- 1997-01-27 CZ CZ982586A patent/CZ258698A3/cs unknown
- 1997-01-27 TR TR1998/01593T patent/TR199801593T2/xx unknown
- 1997-01-27 JP JP52913897A patent/JP3167335B2/ja not_active Expired - Fee Related
- 1997-01-27 EP EP97900401A patent/EP0882044B1/de not_active Expired - Lifetime
- 1997-01-27 AT AT97900401T patent/ATE220676T1/de not_active IP Right Cessation
- 1997-01-27 HN HN1997000013A patent/HN1997000013A/es unknown
- 1997-01-27 PL PL97328514A patent/PL328514A1/xx unknown
- 1997-01-27 HU HU9902810A patent/HUP9902810A3/hu unknown
- 1997-01-27 BR BR9707568A patent/BR9707568A/pt active Search and Examination
- 1997-01-27 DK DK97900401T patent/DK0882044T3/da active
- 1997-02-10 PE PE1997000085A patent/PE36298A1/es not_active Application Discontinuation
- 1997-02-13 CO CO97007547A patent/CO4650041A1/es unknown
- 1997-02-17 AR ARP970100614A patent/AR005841A1/es unknown
- 1997-02-18 HR HRPCT/IB96/00132A patent/HRP970094A2/xx not_active Application Discontinuation
- 1997-02-18 ID IDP970467A patent/ID16434A/id unknown
- 1997-02-18 ZA ZA971357A patent/ZA971357B/xx unknown
- 1997-02-18 MA MA24498A patent/MA26419A1/fr unknown
1998
- 1998-06-25 IS IS4783A patent/IS4783A/is unknown
- 1998-07-10 OA OA9800111A patent/OA10712A/en unknown
- 1998-08-10 BG BG102678A patent/BG102678A/xx unknown
- 1998-08-18 NO NO983776A patent/NO983776L/no unknown

Also Published As

Publication number	Publication date
US6131226A (en)	2000-10-17
ES2177921T3 (es)	2002-12-16
BG102678A (en)	1999-04-30
AR005841A1 (es)	1999-07-14
NO983776D0 (no)	1998-08-18
JP3167335B2 (ja)	2001-05-21
CZ258698A3 (cs)	1999-06-16
HUP9902810A2 (hu)	2000-05-28
CN1211251A (zh)	1999-03-17
DE69714019D1 (de)	2002-08-22
ATE220676T1 (de)	2002-08-15
SI0882044T1 (en)	2002-10-31
KR19990082678A (ko)	1999-11-25
PE36298A1 (es)	1998-07-18
BR9707568A (pt)	1999-07-27
CA2245857A1 (en)	1997-08-21
HRP970094A2 (en)	1998-06-30
NZ325455A (en)	1999-07-29
EP0882044B1 (de)	2002-07-17
DE69714019T2 (de)	2002-11-14
CO4650041A1 (es)	1998-09-03
IS4783A (is)	1998-06-25
TNSN97037A1 (fr)	2005-03-15
HUP9902810A3 (en)	2000-09-28
ID16434A (id)	1997-09-25
OA10712A (en)	2001-06-04
JPH11507949A (ja)	1999-07-13
MA26419A1 (fr)	2004-12-20
TR199801593T2 (xx)	1999-12-21
WO1997030048A1 (en)	1997-08-21
PL328514A1 (en)	1999-02-01
HN1997000013A (es)	1997-06-26
EP0882044A1 (de)	1998-12-09
IL124867A0 (en)	1999-01-26
PT882044E (pt)	2002-11-29
CA2245857C (en)	2002-10-01
AU1396497A (en)	1997-09-02
ZA971357B (en)	1998-08-18
DK0882044T3 (da)	2002-09-02

Publication	Publication Date	Title
TR199801642T2 (xx)	1998-11-23	Tedavide faydal� olan karbamik asitlerin azabisiklik esterleri.
NO990551L (no)	1999-04-07	Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister
NO20050417L (no)	2005-02-17	Azaindol kinase-inhibitorer
EP0948327A4 (de)	2003-04-02	Antidiabetische mittel
NO20056007L (no)	2006-01-19	Dobbel NK1/NK3 antagonister for behandling av schizofreni
NO960393L (no)	1996-07-09	Heterosykliske fenylforbindelser som COX-2-inhibitorer
NO175309C (no)	1994-09-28	Analogifremgangsmåte for fremstilling av nye, terapeutisk virksomme tricykliske, nitrogenholdige forbindelser
DE59510645D1 (de)	2003-05-22	Neue thrombininhibitoren, ihre herstellung und verwendung
NO944911L (no)	1995-06-22	Ikke-peptid-takykininreseptorantagonister
NO944928L (no)	1995-06-22	Fremgangsmåter for inhibering av Alzheimers sykdom
BG100692A (en)	1997-09-30	New heterocyclic compounds
DE60315674D1 (de)	2007-09-27	Neue imidazopyridine und ihre verwendung
BR0211119A (pt)	2005-12-13	Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto
NO176519C (no)	1995-04-19	Analogifremgangsmåte for fremstilling av terapeutisk aktive heterocykliske ketoner
CA2449402A1 (en)	2002-12-12	Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases
DE69108048D1 (de)	1995-04-13	Derivate von hydroxaminsäure und von n-hydroxyharnstoff sowie ihre verwendung.
NO913923L (no)	1991-12-06	17beta-substituerte-4-aza-5alfa-androstan-3-on-derivater ogfremgangsmaate ved fremstilling av disse
TR200000671T2 (tr)	2000-07-21	FP agonistleri olarak yararlı aromatik C16-C20-ikameli tetrahidro prostaglandinler.
LV12291A (lv)	1999-06-20	Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
DE602004016123D1 (de)	2008-10-09	Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
NO983992L (no)	1998-10-30	Serinprotease inhibitorer
DE69831690D1 (de)	2006-02-02	Stickstoffhaltige heterocyclische verbindungen, ihre herstellung und verwendung
ATE241360T1 (de)	2003-06-15	Blutlipoproteinspiegel regulierendes präparat
NO973652L (no)	1997-10-08	5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreseptor-antagonist
NO944933L (no)	1995-06-22	Fremgangsmåte for å inhibere sykdomstilstander i brystet